MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-18-0081212
Zandra Life Sciences Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹54.64 Cr
▲ 12% YoY
Net profit · FY 2025
₹31.43 Lakh
Net margin 0.6%
EBITDA · FY 2025
₹2.03 Cr
EBITDA margin 3.7%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹9.26 Cr
Satisfied ₹7.5 Cr
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
About Zandra Life Sciences Private Limited
Data last updated:
Zandra Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 October 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2010PTC208959. Its GSTIN is 27AAACZ4535C1ZH (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Arun Narayankutty Menon and Anantkumar Pandya Satishbhai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.64 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹31.43 Lakh (net margin 0.6%) and EBITDA of ₹2.03 Cr (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 14% over five years.
The company is associated with 1 brand: Zandra Life Sciences. As per MCA filings, the company has open charges of ₹9.26 Cr and satisfied charges of ₹7.5 Cr on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 3 cases are pending.
Zandra Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0081212). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zandralifesciences.com.
Company Details of Zandra Life Sciences Private Limited
CIN U24100MH2010PTC208959
Registration Number 208959
Incorporation Date 13 October 2010
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0081212
Recognitions & Rankings of Zandra Life Sciences
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressB – 1001 10th Floor O2 Commercial Bldg Near Minerva Indl Estate Nahur Village M, Ulund West, Mumbai, Maharashtra, India – 400080
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Zandra Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Zandra Life Sciences Private Limited
Zandra Life Sciences operates one associated brand: Zandra Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical and nutraceutical solutions, including product identification, registration, distribution, and sales in healthcare. | zandralifesciences.com |
Business Activity of Zandra Life Sciences Private Limited
The main business activity of Zandra Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Zandra Life Sciences Private Limited FY 2025 filings available
Zandra Life Sciences Private Limited reported revenue of ₹54.64 Cr (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹54.64 Cr ▲ 12%
Net profit · FY 2025
₹31.43 Lakh margin 0.6%
EBITDA · FY 2025
₹2.03 Cr margin 3.7%
Compounded Annual Growth Rate (CAGR) of Zandra Life Sciences Private Limited
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 23%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 6%
5 years · compounded
▲ 22%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 12% growth in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Zandra Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.03 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹31.43 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Zandra Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Zandra Life Sciences are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Zandra Life Sciences Private Limited
Zandra Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Narayankutty Menon Also directs: Zupreme Nutrisciences Private Limited | Director | 13 Oct 2010 | 16 Years 0 Months | Current |
| Anantkumar Pandya Satishbhai Also directs: Zupreme Nutrisciences Private Limited, Vinditya LLP | Director | 18 Jan 2012 | 14 Years 9 Months | Current |
Peer Comparison of Zandra Life Sciences Private Limited
Zandra Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sndev Healthcare Limited | ₹55.17 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Kandivlai West, Maharashtra, India |
| Cu-V-Kar Genetic Medicine Private Limited | ₹55.11 Cr (FY 2024) | •••• | •••• | 38.0% | •••• | Chennai, Tamil Nadu, India |
| Prahem Laboratories LLP | ₹54.97 Cr (FY 2024) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Kamla Lifesciences Limited | ₹54.89 Cr (FY 2024) | •••• | •••• | 115.0% | •••• | Boisar, Maharashtra, India |
| KRS Pharmaceuticals Private Limited | ₹54.79 Cr (FY 2025) | •••• | •••• | 60.0% | •••• | Hyderabad, Telangana, India |
| Zandra Life Sciences Private Limited this company | ₹54.64 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Trimurti Distributors Private Limited | ₹54.27 Cr (FY 2025) | •••• | •••• | 1652.0% | •••• | Jalgaon, Maharashtra, India |
| Vim Meditech Private Limited | ₹53.98 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Ahmedabad, Gujarat, India |
| Vital Healthcare Private Limited | ₹53.97 Cr (FY 2024) | •••• | •••• | 221.0% | •••• | Mumbai, Maharashtra, India |
| Akriti Pharmaceuticals Private Limited | ₹53.84 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Thane, Maharashtra, India |
| Rasino Herbs Private Limited | ₹53.81 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Zandra Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Zandra Life Sciences Private Limited
Zandra Life Sciences Private Limited is audited by Rajesh P Shah & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Rajesh P Shah & Co. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Zandra Life Sciences Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Zandra Life Sciences Private Limited
Open charges
₹9.26 Cr
Satisfied charges
₹7.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2022 | Canara Bank | ₹18.7 Lakh | Open |
| 11 Oct 2021 | Canara Bank | ₹17.4 Lakh | Open |
| 14 Sep 2021 | Canara Bank | ₹11.22 Lakh | Open |
| 20 Jul 2021 | Canara Bank | ₹25 Lakh | Open |
| 26 Mar 2021 | Canara Bank | ₹8.54 Cr | Open |
Total charge records: 7 View all charges
Legal Cases of Zandra Life Sciences Private Limited
Zandra Life Sciences Private Limited has 6 court cases on record: 2 filed by Zandra Life Sciences, 4 filed against it. 3 cases are pending and 3 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Total cases
6
Filed by the company
2
Filed against the company
4
Pending
3
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 4 | 3 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Zandra Healthcare Private Limited | Pending |
| Bombay High Court | Court case (COMIP) | Filed by the company against Zandra Healthcare Private Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Zandra Healthcare Private Limited | Disposed |
| Bombay High Court | Court case (APP) | Filed against the company by an individual | Pending |
| Bombay High Court | Court case (NMA) | Filed against the company by an individual | Disposed |
Premium access
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Zandra Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Zandra Life Sciences.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Zandra Life Sciences Private Limited
Zandra Life Sciences Private Limited has 6 board changes on record since 2010: 4 appointments and 2 cessations. The latest: Bansari Anantkumar Pandya ceased to be Director on 21 Mar 2024.
AGM
Zandra Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Zandra Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Canara Bank of Rs. 8.54 Cr registered on 26 Mar 2021 with Charge ID 100440354 was modified on 15 Jun 2024.
Ceased
Bansari Anantkumar Pandya ceased to be Director.
Ceased
Sucheta Arun Menon ceased to be Director.
Charges
A charge with Canara Bank amounted to Rs. 0.19 Cr with Charge ID 100578722 was registered on 05 May 2022.
Charges
A charge with Canara Bank amounted to Rs. 0.17 Cr with Charge ID 100502460 was registered on 11 Oct 2021.
Charges
A charge with Canara Bank amounted to Rs. 0.11 Cr with Charge ID 100502455 was registered on 14 Sep 2021.
Charges
A charge with Canara Bank amounted to Rs. 0.25 Cr with Charge ID 100471150 was registered on 20 Jul 2021.
Charges
A charge registered on 26 Nov 2015 via Charge ID 10613512 with Indian Overseas Bank was fully satisfied on 23 Apr 2021.
Charges
A charge with Canara Bank amounted to Rs. 8.54 Cr with Charge ID 100440354 was registered on 26 Mar 2021.
Charges
A charge with Indian Overseas Bank of Rs. 6.00 Cr registered on 26 Nov 2015 with Charge ID 10613512 was modified on 12 Aug 2020.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Zandra Life Sciences Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Zandra Life Sciences Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Zandra Life Sciences Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Zandra Life Sciences Private Limited
Zandra Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACZ4535C1ZH | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Zandra Life Sciences Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zandra Life Sciences Private Limited
Zandra Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 October 2010 (16+ years old) and is registered under CIN U24100MH2010PTC208959.
Zandra Life Sciences reported revenue of ₹54.64 Cr for FY 2025 (up 12% YoY).
Zandra Life Sciences has 2 current directors:
- Arun Narayankutty Menon - Director
- Anantkumar Pandya Satishbhai - Director
Zandra Life Sciences reported a net profit of ₹31.43 Lakh (net margin 0.6%) and EBITDA of ₹2.03 Cr (EBITDA margin 3.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Zandra Life Sciences is 23% over three years and 14% over five years. In the latest year (FY 2025) revenue rose 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Zandra Life Sciences is 27AAACZ4535C1ZH, registered in Maharashtra.
The CIN (Corporate Identification Number) of Zandra Life Sciences is U24100MH2010PTC208959. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zandra Life Sciences has 6 court cases on record: 2 filed by the company and 4 filed against it. 3 are pending.
Zandra Life Sciences was incorporated on 13 October 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Zandra Life Sciences by revenue are Sndev Healthcare Limited, Cu-V-Kar Genetic Medicine Private Limited, Prahem Laboratories LLP, Kamla Lifesciences Limited, KRS Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Bansari Anantkumar Pandya ceased to be Director on 21 Mar 2024. Sucheta Arun Menon ceased to be Director on 21 Mar 2024. Anantkumar Pandya Satishbhai was appointed as Director on 18 Jan 2012. Zandra Life Sciences has 6 board changes on record in total.